{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:02:05Z","timestamp":1773921725886,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jceh.2025.103459","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T07:44:57Z","timestamp":1766475897000},"page":"103459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Decade Long, Real-life Experience of Sofosbuvir-based Regimen Use for Hepatitis C Treatment in People With End-stage Renal Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Ajay K.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmendra S.","family":"Bhadauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-5534","authenticated-orcid":false,"given":"Surender","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Rungta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Katiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas R.","family":"Behera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Yachha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-9381","authenticated-orcid":false,"given":"Amit","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103459_bib1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jceh.2022.06.003","article-title":"A systematic review of risk factors for hepatitis C virus infection among low-risk population in India","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284169","article-title":"Global epidemiology of hepatitis C virus in dialysis patients: systematic review and meta-analysis","volume":"19","author":"Kenfack-Momo","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103459_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12664-018-0920-3","article-title":"Hepatitis C virus infection and chronic renal disease: a review","volume":"37","author":"Goel","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103459_bib4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2215\/CJN.02510317","article-title":"Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD","volume":"12","author":"Sise","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2025.103459_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5301\/ijao.5000437","article-title":"Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks","volume":"38","author":"Fabrizi","year":"2015","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jceh.2025.103459_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12664-017-0763-3","article-title":"Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: an Indian experience","volume":"36","author":"Goel","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103459_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/jgh.14301","article-title":"Cost-effectiveness of generic pan-genotypic sofosbuvir\/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment","volume":"33","author":"Goel","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12664-017-0745-5","article-title":"Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients","volume":"36","author":"Goel","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103459_bib10","article-title":"Anti-viral efficacy and pharmacokinetics (PK) of sofosbuvir (SOF) in patients with severe renal impairment","volume":"60","author":"Gane","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103459_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.12929","article-title":"Real-world efficacy and safety of universal 8-week glecaprevir\/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: insights from a nationwide hepatisis C virus registry in Taiwan","volume":"41","author":"Wang","year":"2025","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jceh.2025.103459_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/23744235.2015.1078908","article-title":"Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency","volume":"47","author":"Hundemer","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jceh.2025.103459_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2016.02.044","article-title":"Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C","volume":"65","author":"Desnoyer","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib14","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/ndt\/gfaa187","article-title":"Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir","volume":"36","author":"Goel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jceh.2025.103459_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/nep.13222","article-title":"Daclatasvir and reduced-dose sofosbuvir: an effective and pangenotypic treatment for hepatitis C in patients with estimated glomerular filtration rate <30 mL\/min","volume":"24","author":"Goel","year":"2019","journal-title":"Nephrology"},{"key":"10.1016\/j.jceh.2025.103459_bib16","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jceh.2022.06.002","article-title":"Liver stiffness is reduced to normal after successful renal transplantation: a prospective cohort study","volume":"12","author":"Bhadauria","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285725","article-title":"Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-na\u00efve non-cirrhotic patients with chronic hepatitis C virus infection: study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)","volume":"18","author":"Awasthi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103459_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jgh.14466","article-title":"Burden of hepatitis C virus infection in India: a systematic review and meta-analysis","volume":"34","author":"Goel","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jgh.15827","article-title":"Seroprevalence and burden of hepatitis C virus infection in WHO south-east Asia region: a systematic review","volume":"37","author":"Goel","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2025.103459_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.kisu.2018.06.001","article-title":"KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"8","year":"2018","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jceh.2025.103459_bib21","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s10620-018-4979-6","article-title":"Low-dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end-stage renal disease","volume":"63","author":"Taneja","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2025.103459_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/apt.14429","article-title":"Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis","volume":"47","author":"He","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2025.103459_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jceh.2019.10.004","article-title":"Sofosbuvir-velpatasvir fixed drug combination for the treatment of chronic hepatitis C infection in patients with end-stage renal disease and kidney transplantation","volume":"10","author":"Gaur","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103459_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2019.05.028","article-title":"Sofosbuvir\/velpatasvir for 12weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis","volume":"71","author":"Borgia","year":"2019","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325009594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:40:33Z","timestamp":1773906033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325009594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0973688325009594"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103459","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Decade Long, Real-life Experience of Sofosbuvir-based Regimen Use for Hepatitis C Treatment in People With End-stage Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103459"}}